Related Experiment Videos
Reducing the immune response to immunotoxin
1Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. afrankel@wfubmc.edu
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans.
Medical research archives·2022
Same author
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood·2022
Same author
Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.
The Israel Medical Association journal : IMAJ·2022
Same author
Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
Angiogenesis·2022
Same author
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus.
Clinical case reports·2021
Same author
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib.
Clinical case reports·2021
Same journal
Claudin 18.2 Targeting: A Pan-Cancer Perspective.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal
Camrelizumab, a patinib and radiotherapy in locally advanced, unresectable hepatocellular carcinoma: a phase 2 study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026